Carbamazepine
NDC 75834-220, Carbamazepine, tablet, from NIVAGEN PHARMACEUTICALS, INC..
- Product NDC
- 75834-220
- Status
- Listed
- Labeler
- NIVAGEN PHARMACEUTICALS, INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207798
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75834-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBAMAZEPINE100 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75834-220-00 | 75834022000 | 1000 TABLET in 1 BOTTLE (75834-220-00) |
| 75834-220-01 | 75834022001 | 100 TABLET in 1 BOTTLE (75834-220-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e68998cb-5f91-4d7e-85a6-555efb8b0384
Use it
Look up 75834-220 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75834-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75834-220. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.